Tramadol is addictive, though less so than stronger opioids like oxycodone or hydromorphone. It was classified as a Schedule IV controlled substance by the DEA in 2014, a category reserved for drugs with a low but real potential for abuse and dependence. That “low” label, however, has led many people to underestimate the risk. Regular use of tramadol, even at standard prescribed doses of 200 mg per day, can produce physical dependence characteristic of other opioids.
How Tramadol Works in the Body
Tramadol is unusual among painkillers because it works through two separate mechanisms. Part of the drug activates the same opioid receptors targeted by morphine and codeine, producing pain relief and mild euphoria. At the same time, tramadol blocks the reabsorption of serotonin and norepinephrine, two brain chemicals involved in mood and pain signaling. This dual action is why tramadol was originally thought to carry little addiction risk: its opioid effects are weaker and slower to kick in than those of traditional painkillers.
But the body doesn’t leave tramadol alone. A liver enzyme called CYP2D6 converts tramadol into a more potent form that binds opioid receptors up to six times more strongly than the original drug. How much of this active form you produce depends on your genetics, which is one reason tramadol affects people so differently.
Why Some People Are at Higher Risk
About 1 to 2 percent of the population are “ultrarapid metabolizers,” meaning their bodies convert tramadol into its stronger form much faster and in greater quantities. For these individuals, a standard dose can feel more like a full-strength opioid, increasing both the risk of side effects and the likelihood of developing a pattern of misuse. The FDA’s drug label explicitly warns that ultrarapid metabolizers should not use tramadol because of the risk of life-threatening respiratory depression.
On the other end of the spectrum, “poor metabolizers” barely convert tramadol at all, getting little pain relief and potentially taking more than prescribed in an attempt to make the drug work. People with a personal or family history of substance use disorders are also at elevated risk. Clinical guidelines recommend that tramadol not be prescribed to individuals who are prone to addiction, suggesting non-narcotic alternatives instead.
Physical Dependence vs. Addiction
These two terms are often confused, but they describe different things. Physical dependence means your body has adapted to the drug’s presence and will react when you stop taking it. Addiction involves compulsive use despite harm: craving the drug, losing control over how much you take, continuing even when it damages your health or relationships.
Research shows that tramadol reliably produces physical dependence at normal therapeutic doses. Your body adjusts to having the drug in its system, and stopping abruptly triggers withdrawal. But the subjective “high” from tramadol is modest and delayed compared to stronger opioids, which is the main reason its abuse rates remain lower. The drug’s low abuse profile has more to do with its weak and slow-onset euphoria than with any inability to cause dependence.
This distinction matters because even people who take tramadol exactly as prescribed can develop dependence and face withdrawal. That doesn’t mean they’re addicted, but it does mean they can’t simply stop taking it one day without consequences.
What Withdrawal Looks Like
Tramadol withdrawal involves two layers of symptoms because of the drug’s dual mechanism. The opioid side produces classic withdrawal effects: stomach pain, diarrhea, nausea, bone pain, excessive sweating, runny nose, and insomnia. The serotonin and norepinephrine side adds a set of symptoms not typically seen with other opioids, including severe anxiety, panic attacks, confusion, numbness or tingling, and in some cases hallucinations. Visual and auditory hallucinations have been reported in roughly 20 percent of withdrawal cases in clinical literature.
More unusual psychological symptoms like paranoia, feelings of unreality, and depersonalization occur at lower rates but are well documented. These atypical symptoms are what set tramadol withdrawal apart from withdrawal caused by other opioids, and they can be alarming for people who aren’t expecting them. Most of these effects subside within days to a couple of weeks once the withdrawal period resolves, but the unpredictability of symptoms is one reason medical supervision during tapering is strongly recommended.
Seizure Risk at Higher Doses
One of tramadol’s most serious risks is seizures, particularly at doses above the recommended maximum of 400 mg per day. The seizure risk comes largely from tramadol’s serotonin activity: when too much serotonin builds up in the brain, it can trigger a dangerous condition called serotonin syndrome, which includes seizures as a hallmark feature. This risk climbs further if you’re also taking antidepressants (SSRIs or tricyclics), which raise serotonin levels through their own mechanisms.
Importantly, seizures can also occur within the normal dose range in some people because of genetic differences in how quickly the drug is metabolized. This makes tramadol somewhat less predictable than other painkillers when it comes to dose-related complications.
Signs of Tramadol Misuse
Because tramadol is seen as a “safer” painkiller, misuse can develop gradually and go unrecognized. Common patterns include taking more than prescribed to chase pain relief or mild euphoria, refilling prescriptions early, obtaining tramadol from multiple doctors, or continuing to use it after the condition it was prescribed for has resolved. A Danish autopsy study spanning 2013 to 2024 found that among 205 people who died with tramadol in their system, 40 percent had no prescription for the drug, suggesting a substantial proportion of tramadol use occurs outside medical supervision.
Behavioral changes can also signal a problem: increasing preoccupation with when the next dose is due, social withdrawal, mood swings between doses, and defensiveness when the topic of medication use comes up. The transition from dependence to addiction is often gradual, which is why these early patterns are worth paying attention to.
How Tramadol Dependence Is Treated
The standard approach is a gradual taper rather than stopping cold turkey. In clinical settings, doses are typically reduced by about 20 percent every two days over a period of roughly 11 days, though the exact schedule varies based on how much you’ve been taking and for how long. Tapering reduces the severity of withdrawal symptoms and lowers the risk of complications like seizures.
For people with more severe dependence, doctors sometimes use medications that ease withdrawal by stabilizing opioid receptors in the brain, allowing a smoother transition off the drug. Supportive care for anxiety, insomnia, and gastrointestinal symptoms is common during the tapering process. Psychological support, whether through counseling or structured recovery programs, helps address the behavioral patterns that may have developed around tramadol use, particularly for those whose use escalated beyond the original prescription.